NCI Rising Scholars: Cancer Research Seminar Series

NCI Rising Scholars: Cancer Research Seminar Series

Center for Cancer Training, National Cancer Institute

The National Cancer Institute (NCI) Center for Cancer Training hosts the virtual NCI Rising Scholars: Cancer Research Seminar Series showcasing the research of early career cancer researchers supported by the NCI.

Across all NCI training programs, we aim to catalyze the development of a workforce capable of advancing cancer research through a scientifically integrated approach. We accomplish this by providing research training and career development activities for scholars inside NCI’s research groups and by supporting funding opportunities for training in cancer research, career development, and research education. This monthly virtual seminar series is an opportunity to highlight the research and the important contributions made by NCI-supported postdoctoral scholars and early career investigators.

Speakers for the year are selected by the NCI Center for Cancer Training, Cancer Training Branch. We identify all first-author research articles each calendar year published by individuals who are postdoctoral scholars at NCI and those who hold active NCI career development awards and cite the NCI award in the article. The field citation rate and number of citations the article has received to date is taken into consideration. We aim to select research areas spanning the cancer continuum across different cancer organ sites. Additionally, we aim to invite speakers from distinct geographical locations throughout the United States.

Speakers
Community
Center for Cancer Training
Center for Cancer Training

Upcoming live seminars

March 2025

SuMoTuWeThFrSa
1
2345678
9101112131415
16171819202122
23242526272829
3031

NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis

AP
Abhijit Parolia
Thursday, March 20, 2025 6:00 PM (UTC)
RSVP to seminar

April 2025

SuMoTuWeThFrSa
12345
6789101112
13141516171819
20212223242526
27282930
Memorial Sloan Kettering Cancer Center
Rockefeller University

Fc-optimized CD40 Agonistic Antibody Induces Tertiary Lymphoid Structures and Systemic Antitumor Immunity in Metastatic Cancer Patients

Dr. Juan C. Osorio
Juan C. Osorio
Memorial Sloan Kettering Cancer Center and Rockefeller University
Thursday, April 17, 2025 6:00 PM (UTC)
RSVP to seminar

May 2025

SuMoTuWeThFrSa
123
45678910
11121314151617
18192021222324
25262728293031
Michigan State University

Systemwide characterization of the ERK program that drives pancreatic cancer

Dr Jennifer E. Klomp MS PhD
Jennifer E. Klomp
Michigan State University
Thursday, May 15, 2025 6:00 PM (UTC)
RSVP to seminar

June 2025

SuMoTuWeThFrSa
1234567
891011121314
15161718192021
22232425262728
2930
University of Rochester Medical Center

A scoping review of racial, ethnic, socioeconomic, and geographic disparities in the outcomes of older adults with cancer

Dr Nikesha Gilmore PhD
Nikesha Gilmore
University of Rochester Medical Center
Thursday, June 12, 2025 6:00 PM (UTC)
RSVP to seminar

July 2025

SuMoTuWeThFrSa
12345
6789101112
13141516171819
20212223242526
2728293031
National Cancer Institute

Extracellular Matrix Scaffold-Assisted Tumor Vaccines Induce Tumor Regression and Long-Term Immune Memory

Dr. Sanjay Pal Ph.D.
Sanjay Pal
National Cancer Institute
Thursday, July 17, 2025 6:00 PM (UTC)
RSVP to seminar

August 2025

SuMoTuWeThFrSa
12
3456789
10111213141516
17181920212223
24252627282930
31
University of Washington
Fred Hutch Cancer Center

Radiation for high-risk asymptomatic bone metastases – an implementation science perspective

Dr. Erin Gillespie
Erin Gillespie
University of Washington and Fred Hutch Cancer Center
Thursday, August 21, 2025 6:00 PM (UTC)
RSVP to seminar

September 2025

SuMoTuWeThFrSa
123456
78910111213
14151617181920
21222324252627
282930
Emory University

Multilevel Predictors of Racial and Ethnic Disparities in Ovarian Cancer Outcomes

Dr. Lindsay Collin
Lindsay Collin
Emory University
Thursday, September 18, 2025 6:00 PM (UTC)
RSVP to seminar

October 2025

SuMoTuWeThFrSa
1234
567891011
12131415161718
19202122232425
262728293031
Memorial Sloan Kettering Cancer Center

Xpert Breast Cancer STRAT4 Assay using fine-needle aspiration biopsy samples in a resource-constrained setting: a prospective diagnostic accuracy study.

Dr.  Dianna Ng MD
Dianna Ng
Memorial Sloan Kettering Cancer Center
Thursday, October 16, 2025 6:00 PM (UTC)
RSVP to seminar

November 2025

SuMoTuWeThFrSa
1
2345678
9101112131415
16171819202122
23242526272829
30
Dana-Farber Cancer Institute
Harvard Medical School

Eligibility criteria and representative cancer clinical trials

Dr. Andrew Hantel MD
Andrew Hantel
Dana-Farber Cancer Institute and Harvard Medical School
Thursday, November 20, 2025 7:00 PM (UTC)
RSVP to seminar

December 2025

SuMoTuWeThFrSa
123456
78910111213
14151617181920
21222324252627
28293031

Published seminars

UC San Diego Health System

Barriers and facilitators of Hispanic/Latino parents caregiving for a childhood cancer survivor: a qualitative study

Carol Ochoa Dominguez, UC San Diego Health System
National Cancer Institute

An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings

Kathryn Kundrod, National Cancer Institute
Dana-Farber Cancer Institute

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Jacqueline S. Garcia, Dana-Farber Cancer Institute
University of California, San Francisco

Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer

Jonathan Chou, University of California, San Francisco
University of Pennsylvania

Patient‐reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis

Oluwadamilola M. Fayanju, University of Pennsylvania
University of Pittsburgh

Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer

Dave Gau, University of Pittsburgh
University of Mississippi

Redlining-associated methylation in breast tumors: the impact of contemporary structural racism on the tumor epigenome

Jasmine Miller-Kleinhenz, University of Mississippi
Dana-Farber Cancer Institute

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Erin M. Parry, Dana-Farber Cancer Institute
Northwestern University

HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer

Lillian J. Eichner, Northwestern University